Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABBR2 | O75899 | 2/20 | 0.55 |
| ▸ | GABBR1 | Q9UBS5 | 2/20 | 0.55 |
| ▸ | TAAR1 | Q96RJ0 | 6/20 | 0.54 |
| ▸ | HTR2A | P28223 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.45 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.45 |
| ▸ | HRH1 | P35367 | 1/20 | 0.44 |
| ▸ | CCR5 | P51681 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL429745 | 1.00 | GABBR2 (0.55) | GABBR2GABBR1TAAR1HTR2ALMNA | |
| SCHEMBL2344157 | 1.00 | GABBR2 (0.55) | GABBR2GABBR1TAAR1HTR2ALMNA | |
| Hydrochloric Acid SCHEMBL2346631 | 0.98 | GABBR2 (0.53) | GABBR2GABBR1TAAR1HTR2ALMNA | |
| SCHEMBL17906514 | 0.87 | CHRNB2 (0.59) | GABBR2GABBR1TAAR1HTR2ACHRNB2 | |
| Methylamine SCHEMBL27931105 | 0.85 | LMNA (0.52) | GABBR2GABBR1TAAR1HTR2ALMNA | |
| SCHEMBL1539105 | 0.85 | TAAR1 (0.65) | GABBR2GABBR1TAAR1HTR2ACHRNB2 | |
| SCHEMBL169508 | 0.85 | LMNA (0.56) | TAAR1HTR2ALMNAHRH1CCR5 | |
| Hydrochloric Acid SCHEMBL10676327 | 0.82 | TAAR1 (0.62) | GABBR2GABBR1TAAR1HTR2ACHRNB2 | |
| Ammonia Solution, Strong SCHEMBL1640901 | 0.82 | LMNA (0.54) | TAAR1HTR2ALMNAHRH1CCR5 | |
| SCHEMBL19734403 | 0.82 | GABBR2 (0.52) | GABBR2GABBR1TAAR1HTR2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 392 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119233997-A | Tetrahedral antibodies | 生物分子控股有限责任公司 | 2024-12-31 | — | — | CN | claimed |
| EP-4463485-A2 | TETRAHEDRAL ANTIBODIES | Biomolecular Holdings LLC (US) | 2024-11-20 | — | — | EP | claimed |
| US-20230364224-A1 | Pharmaceutical Composition For Allergen Specific Immunotherapy | HOPITAUX UNIVERSITAIRES DE GENEVE (CH) | 2023-11-16 | — | — | US | claimed |
| EP-4213873-A1 | COMPOSITE SOLDER BALLS METALLISED ON THE SURFACE AND CALIBRATED FOR THE ASSEMBLY OF ELECTRONIC BOARDS | Hopitaux Universitaires de Genève (CH) | 2023-07-26 | — | — | EP | claimed |
| WO-2023137373-A1 | TETRAHEDRAL ANTIBODIES | BIOMOLECULAR HOLDINGS LLC (US) | 2023-07-20 | — | — | WO | claimed |
| WO-2023137387-A2 | TETRAHEDRAL ANTIBODIES | BIOMOLECULAR HOLDINGS LLC (US) | 2023-07-20 | — | — | WO | claimed |
| US-20230220115-A1 | TETRAHEDRAL ANTIBODIES | BIOMOLECULAR HOLDINGS LLC (US) | 2023-07-13 | — | — | US | claimed |
| US-20230220116-A1 | TETRAHEDRAL ANTIBODIES | BIOMOLECULAR HOLDINGS LLC (US) | 2023-07-13 | — | — | US | claimed |
| EP-4178615-A1 | TETRAHEDRAL ANTIBODIES | Biomolecular Holdings LLC (US) | 2023-05-17 | — | — | EP | claimed |
| WO-2022058432-A1 | PHARMACEUTICAL COMPOSITION FOR ALLERGEN SPECIFIC IMMUNOTHERAPY | Hôpitaux Universitaires de Genève (CH) | 2022-03-24 | — | — | WO | claimed |
| EP-2655314-A1 | MULTI- API LOADING PRODRUGS | Alkermes Pharma Ireland Limited (IE) | 2013-10-30 | — | — | EP | claimed |
| US-20130184265-A1 | Prodrugs of Secondary Amine Compounds | ALKERMES PHARMA IRELAND LIMITED (IE) | 2013-07-18 | — | — | US | claimed |
| WO-2013088255-A1 | PRODRUGS OF SECONDARY AMINE COMPOUNDS | ALKERMES PHARMA IRELAND LIMITED (IE) | 2013-06-20 | — | — | WO | claimed |
| WO-2012088441-A1 | MULTI- API LOADING PRODRUGS | ALKERMES, INC. (US) | 2012-06-28 | — | — | WO | claimed |
| CN-1343024-A | Organic amine used as additive in electrochemical battery | MERCK PATENT GMBH (DE) | 2002-04-03 | — | — | CN | claimed |
| EP-1187244-A2 | Organic amines as additives for electrochemical cells | MERCK PATENT GmbH (DE) | 2002-03-13 | — | — | EP | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| US-4995997-A | Containing aromatic amine | YUSHIRO CHEMICAL INDUSTRY CO., LTD. (JP) | 1991-02-26 | — | — | US | claimed |
| EP-0388320-A1 | Antibacterial water-soluble cutting fluids resistant to yeast-like fungi | YUSHIRO CHEMICAL INDUSTRY CO. LTD. (JP) | 1990-09-19 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230220115-A1 | TETRAHEDRAL ANTIBODIES | FCGR3B, FCGR2A, FCGR1A | GABBR2 3094/4885GABBR1 3474/4885TAAR1 3652/4885 |
| US-20230220116-A1 | TETRAHEDRAL ANTIBODIES | FCGR3B, FCGR2A, FCGR1A | GABBR2 3094/4885GABBR1 3474/4885TAAR1 3652/4885 |
| US-20130184265-A1 | Prodrugs of Secondary Amine Compounds | HNMT, MAOB, UGT1A1 | GABBR2 1127/4885GABBR1 791/4885TAAR1 125/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.